Sign In

Andrew Hotchkiss

Chief Executive Officer at Draupnir Bio

Andrew Hotchkiss is a seasoned professional with a distinguished career spanning over 30 years in the pharmaceutical and biotech industry.

He has a strong background in various therapeutic areas such as Anti-Infectives, CNS, Diabetes, Oncology, Bone, Immunology, and Neuro-degeneration.

Andrew's expertise lies in leadership roles encompassing sales, marketing, corporate and commercial strategy, country management, business development, regional leadership positions, digital strategy, and industry trade associations.

His educational background includes studying Biochemistry at Cardiff University / Prifysgol Caerdydd.

Notable positions in his career include Chief Executive Officer at Draupnir Bio, Chief Commercial Officer at Immunocore, President Europe, Australia, and Canada at Eli Lilly and Company, among others.

Andrew Hotchkiss has a wealth of experience in leading organizations and driving growth and innovation in the pharmaceutical and biotech sectors.

Highlights

Jun 23 · draupnir.bio
Andrew Hotchkiss joins Draupnir Bio as Chief Executive Officer
Jun 23 · globenewswire.com
Andrew Hotchkiss joins Draupnir Bio as Chief Executive Officer
Jun 23 · pm360online.com
Andrew Hotchkiss joins Draupnir Bio as Chief Executive Officer

Related Questions

What are Andrew Hotchkiss's key achievements at Dermira?
How did Andrew Hotchkiss's role at Immunocore prepare him for his position at Draupnir Bio?
What specific strategies did Andrew Hotchkiss implement at Lilly?
What is the significance of Andrew Hotchkiss's experience in dermatology for his role at Draupnir Bio?
How does Andrew Hotchkiss plan to address cardiovascular disease at Draupnir Bio?
Andrew Hotchkiss
Andrew Hotchkiss, photo 1
Andrew Hotchkiss, photo 2
Add to my network

Location

Greater Guildford Area, United Kingdom